De Novo versus Relapse of Glomerulonephritis Post COVID-19 Vaccination: Case Series in a Single Center in Saudi Arabia
Author(s): Alhwiesh A, Alayoobi L, Ibrahim M, Nasreldin M, Alnokeety M, Aljenaidi H, Mostafa W, Alyousef M, Alnemer A, Alsolami S, Sharofna K, Alfalah K, Almarri Z, Alquraish K
The development of de novo or relapse of an already existing glomerular disease has been reported in association with some COVID-19 vaccinations, specifically the mRNA vaccines. Although reported cases are sparse and the number of reported cases are considered low in comparison to the total number of administered vaccine doses worldwide, the healthcare providers as well as the patients should be aware about such a serious complication in order to provide prompt and proper management. Here we report 3 cases of glomerular diseases in relation to COVID-19 vaccination. One case of IgA nephropathy, a case of IgA vacuities and nephropathy and a case of a relapse of a minimal change disease.